ArticleCureus2025
Evaluating Quality of Life of Prostate Cancer Patients After Radical Prostatectomy.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association between postoperative urinary incontinence severity and anxiety in patients with prostate cancer: A chain mediation analysis of ehealth literacy and pelvic floor muscle training adherence.Asia-Pacific journal of oncology nursing · 2026Article
- Six-month outcomes of a three-arm prospective study comparing Da Vinci vs. Hugo RAS vs. versius robotic radical prostatectomy: (the COMPAR-P trial).Journal of robotic surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Prostate cancer is the second most commonly diagnosed cancer globally and has a significant impact on patients' quality of life (QoL). The treatment of prostate cancer, particularly through radical prostatectomy, offers curative benefits but often results in adverse effects such as urinary incontinence and erectile dysfunction. These issues can persist long after treatment, affecting both physical and mental well-being. Beyond these complications, patients may also experience emotional distress, anxiety, and social implications, such as changes in relationships and self-perception. As such, evaluating QoL post-treatment is essential in understanding the comprehensive impact of prostate cancer care. Methodology This study involved 110 prostate cancer patients who underwent radical prostatectomy. QoL was assessed using the Short-Form Health Survey Questionnaire (SF-36) at the following three points: before treatment and at six and 12 months post-treatment. The evaluation focused on physical, emotional, and social aspects of health. Patients with psychiatric disorders or those unable to understand Greek were excluded from the study. Results The study participants' average age ranged from 67 to 82 years (mean = 74.2 years). A significant improvement in social functioning was observed between the first and second assessments. Improvements were also seen in physical functionality, emotional well-being, and general health, but these changes were not statistically significant. By the third assessment (12 months post-surgery), significant improvements were noted in vitality, though other changes, including in physical, emotional, and role functioning, were not significant. Conclusions Radical prostatectomy is effective for cancer control but often results in persistent QoL issues such as erectile dysfunction and urinary incontinence. While there are improvements in certain areas such as vitality and social functioning, managing the full spectrum of physical and psychosocial impacts requires a holistic approach. Incorporating psychological support and sexual rehabilitation into treatment plans is essential to enhance the QoL of prostate cancer patients. The integration of patient-reported outcomes in clinical care is crucial for ensuring comprehensive and effective treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.